SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-043614
Filing Date
2018-08-10
Accepted
2018-08-10 16:16:28
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv499438_10q.htm 10-Q 222026
2 EXHIBIT 31.1 tv499438_ex31-1.htm EX-31.1 10459
3 EXHIBIT 31.2 tv499438_ex31-2.htm EX-31.2 10531
4 EXHIBIT 32.1 tv499438_ex32-1.htm EX-32.1 4684
5 EXHIBIT 32.2 tv499438_ex32-2.htm EX-32.2 4709
  Complete submission text file 0001144204-18-043614.txt   1981896

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20180630.xml EX-101.INS 474195
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20180630.xsd EX-101.SCH 20409
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20180630_cal.xml EX-101.CAL 12485
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20180630_def.xml EX-101.DEF 103285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20180630_lab.xml EX-101.LAB 120624
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20180630_pre.xml EX-101.PRE 123112
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 181009038
SIC: 2836 Biological Products, (No Diagnostic Substances)